GlassScriptPhysician profile
Vivek Nadipalli
NPI 1942839535
$2,610.84
in general payments reported to CMS, 2019-2025
15 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.22 · 2023: $180 · 2024: $740 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,592.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $418.63 | 2024-2025 | Andexxa, Lokelma, Wainua |
| Amgen INC. | $412.19 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $285.33 | 2023-2025 | Watchman Flx, Watchman |
| E.R. Squibb & Sons, L.L.C. | $281.58 | 2024-2025 | Camzyos |
| Alnylam Pharmaceuticals INC. | $223.96 | 2025 | Amvuttra |
| Inari Medical, INC. | $172.42 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $135.89 | 2025 | |
| Philips North America LLC | $107.80 | 2023 | |
| Penumbra, INC. | $107.00 | 2025 | Indigo System |
| Medtronic, INC. | $106.47 | 2025 | In.Pact Admiral, Corevalve Evolut R |
| Baxter Healthcare | $106.16 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bridgebio Pharma, INC. | $94.67 | 2025 | Attruby |
| Heartflow, INC. | $85.88 | 2025 | |
| Stryker Corporation | $54.95 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Abbott Laboratories | $17.91 | 2025 | Perclose Prostyle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Nadipalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.